Enlivex says it acquired 3 billion Rain tokens at a discount and extended its option to purchase billions more discounted tokens until late next year.
Immunotherapy company Enlivex has raised $21 million via a debt financing agreement to purchase another 3 billion tokens tied to the prediction market platform Rain.
Enlivex said on Tuesday it exercised an option to acquire another 3 billion Rain (RAIN) tokens at a 62% discount for $10 million on Sunday while extending its option to purchase another 272.1 billion RAIN tokens at the same price to December 2027. The debt financing came from The Lind Partners, a New York-based asset manager.
“We are continuing to execute our prediction markets treasury strategy, and we are pleased that Lind provided us with substantial capital, allowing us to continue the execution of our operating plan, as well as to acquire approximately three billion additional RAIN tokens,” said Enlivex executive chair Shai Novik.
